Generative AI designs DNA that activates only in cancer cells; open-source Chorus lets agents talk to the genome
lucapinello · x · 2026-11-18
On the Galaxy Balance podcast, Locium co-founder Luca Pinello discusses generative AI for designing synthetic regulatory DNA that switches genes on only in target cells like cancer cells. Locium runs a closed loop: regulatory atlases → generative models (DNA-Diffusion, CODA) → massively parallel reporter assays validating hundreds of thousands of designs. Pinello authored enhancer work underpinning Casgevy, the first FDA-approved CRISPR therapy, and released Chorus, an open-source tool for AI agents to converse with the genome. The talk also covers AI-designed pathogen risks and agentic scientific discovery.
More from Apps
- Scoble tries J.Doe, a proactive personal AI that suggests tasks via swipeable cards — Scobleizer · 2026-11-18
- Crossmint open-sources Menta, a plugin that lets AI agents complete purchases at 91% success across 3,000 stores — heyshrutimishra · 2026-11-18
- What can you actually take with you when switching AI assistants? — sujingshen · 2026-11-18
- Google open-sources StreetReaderAI, a multimodal map app for blind street exploration — jonfroehlich · 2026-11-18
- Mistral plays catch-up with Vibe Desktop as rivals command full OSes — The Decoder · 2026-11-18
- Bluedot launches phone call recording with instant transcripts and AI notes — dr_cintas · 2026-11-18